鶹Ӱ

Skip to main content

All News

ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.

1 - 10 of 188 Results

Illustration of melting point of lithium chloride, which is shown with green and blue structures in two rows.

Scientists have developed a new machine learning approach that accurately predicted critical and difficult-to-compute properties of molten salts, materials with diverse nuclear energy applications. 

Illustration of an amino acid molecule that is going through a process from air to water with three phases, split into bubbles

Using the now-decommissioned Summit supercomputer, researchers at ORNL ran the largest and most accurate molecular dynamics simulations yet of the interface between water and air during a chemical reaction. The simulations have uncovered how water controls such chemical reactions by dynamically coupling with the molecules involved in the process. 

Scientist standing beside mass spectrometry equipment in a laboratory, with instrumentation panels and analysis tools visible in the background

Robert “Bob” Hettich, an ORNL Corporate Fellow, is a pioneer in using mass spectrometry to uncover how microbes interact within complex environments and influence larger systems like plants and humans. A founder of the field of metaproteomics, he leads research that supports bioenergy, environmental resilience and health through advanced protein analysis.

Two cylinders on each side of the photo are pointing to bright glowing orb in the center.

Scientists at ORNL have developed a method that can track chemical changes in molten salt in real time — helping to pave the way for the deployment of molten salt reactors for energy production.

Secretary Wright leans over red computer door, signing with silver sharpie as ORNL Director Stephen Streiffer looks on

During his first visit to Oak Ridge National Laboratory, Energy Secretary Chris Wright compared the urgency of the Lab’s World War II beginnings to today’s global race to lead in artificial intelligence, calling for a “Manhattan Project 2.”

Neus Domingo Marimon, ORNL scientist, poses for a photo in black with hair down

Neus Domingo Marimon, leader of the Functional Atomic Force Microscopy group at the Center for Nanophase Materials Sciences of ORNL, has been elevated to senior member of the Institute of Electrical and Electronics Engineers.

the foreground shows new macromolecules that could be made using a process invented by Oak Ridge National Laboratory chemists to upcycle the polymers from discarded plastics.

By editing the polymers of discarded plastics, ORNL chemists have found a way to generate new macromolecules with more valuable properties than those of the starting material.

Procter & Gamble scientists used ORNL’s Summit supercomputer to create a digital model of the corneal epithelium, the primary outer layer of cells covering the human eye, and test that model against a series of cleaning compounds in search of a gentler, more environmentally sustainable formula.

P&G is using simulations on the ORNL Summit supercomputer to study how surfactants in cleaners cause eye irritation. By modeling the corneal epithelium, P&G aims to develop safer, concentrated cleaning products that meet performance and safety standards while supporting sustainability goals.

ORNL chemist Benjamin Manard is posing for a photo with a light blue and navy background

Benjamin Manard, a nuclear analytical chemist at ORNL, has been named the 2025 winner of the Emerging Leader in Atomic Spectroscopy Award from Spectroscopy magazine. 

A male researcher is standing next to a poster board displayed on an easel to the right. The researcher is dressed in professional attire, and the poster board is positioned beside him, showing research or visual information.

Ryan Culler is the program manager at Oak Ridge National Laboratory, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care.